Avastin® (bevacizumab) Treatment for mCRC, NSCLC, mBC and mRCC in Combination with Chemotherapy

Educational Webcast

Educational Webcast

Prof Antonio González‐Martín discusses Avastin front‐line in women with advanced ovarian cancer

Educational webcast

Challenges in the treatment of mCRC

Prof Dirk Arnold
Germany

More
Controlling angiogenesis to control tumour growth

Avastin precisely targets VEGF to inhibit angiogenesis for continuous tumour control

More
Patient case

A patient with centrally located adenocarcinoma of the lung

Dr Martin Reck
Germany

More

Expert perspectives

Targeting angiogenesis

Prof Joaquin Bellmunt
Spain

More
Angiogenesis, VEGF and the MoA of Avastin

Precise VEGF inhibition with Avastin is a proven anti‐ tumour strategy

More
Expert perspectives in NSCLC

Avastin in a lung cancer patient

Prof Jürgen Wolf
Germany

More

<>

Resources
Webcasts
Patient Cases

Expert perspectives in CRC
Impact of Avastin in CRC (Prof Eric van Cutsem)
View
Avastin in patients with CNS mets
Risk of cerebral haemorrhage, in the presence of CNS metastases.
View
Expert perspective
Importance of prolonging life (Prof Manuela Schmidinger)
View

Inhibiting angiogenesis
Inhibiting angiogenesis: a mechanistic evaluation (Prof Román Pérez‐Soler)
View
From tumour biology to biomarkers
An insight into the evolving role of biomarkers for anti-angiogenesis therapy in oncology (Dr Donald McDonald)
View
Role of continued anti-VEGF therapy
A summary of data supporting the use of Avastin until disease progression to achieve maximum benefit (Dr Mark Kozloff)
View

NSCLC patient case
A patient with adenocarcinoma of the lung and pre-existing hypertension (Dr Monika Serke)
View
mBC patient case
Triple-negative breast cancer patient with pre-existing controlled hypertension (Dr Paulo Cortes)
View
CRC patient case
A patient with colon adenocarcinoma with borderline resectable liver-only metastases (Dr Mark Kozloff)
View

Upcoming Conferences

EAU
,
Paris, France

24-28 February 2012
EBCC
,
Vienna, Austria

21-24 March 2012
AACR
,
Chicago, IL, USA

31 March 2012 - 04 April 2012

More upcoming conferences

AVASTIN INDICATIONS

USEFUL AVASTIN RESOURCES

GET MORE INFORMATION ABOUT AVASTIN

Disclaimer: Avastin.net is a comprehensive resource for healthcare professionals outside the US. If you are a US resident please visit www.avastin.com. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

You are now leaving the www.avastin.net website. Links to all external sites are provided as a resource to our visitors. Hoffmann-La Roche Inc. ("Roche") accepts no responsibility for the content of these sites. Roche does not control these sites, and the opinions, claims, or comments expressed on these sites should not be attributed to Roche, except where indicated. We recommend that you consult with your physician or other healthcare provider to obtain more information about any Roche prescription medication.